Latest from Healthcare

University spin-out joins junior stock market

Retroscreen Virology Group has joined AIM through an initial public offering (IPO) worth £15 million.

Four Seasons Health Care has 445 care homes and 61 specialist units in the UK

Terra Firma pays £825 million for Four Seasons

Private equity firm Terra Firma has followed up on its recent acquisition of The Garden Centre Group by acquiring care homes provider Four Seasons Health Care.

New listing for NMC

UAE-based healthcare provider NMC Health has commenced conditional dealings on the premium listing segment of the London Stock Exchange.

Vita Liberata CEO Alyson Hogg

Global expansion finance for Vita Liberata

Broadlake Capital has closed its 15th deal in the last seven years through the backing of celebrity-endorsed Vita Liberata.

Abingdon Health inks £2 million investment

Following on from its investment into Econic Technologies, Imperial Innovations Group has made a diagnostics investment.

Alongside Foresight's £1.25 million allocation, Biofortuna raised an additional £850,000

Biotech business nets Foresight capital

A growth capital investment from Foresight Group means that Biofortuna will be able to target regulatory approvals in the US.

Energist provies products used for the removal of hair

MBI sees new backers for Energist

Following nine years of private equity investment, Energist has secured the backing of two new firms as it looks to expand internationally.

Peckforton nets further investment 

A week after deploying its new MEZZ fund for the first time, YFM Equity Partners has re-invested in Peckforton Pharmaceuticals.

Apposite realises SureCalm investment

SureCalm Healthcare has moved away from private equity ownership following its sale to ConvaTec subsidiary business Amcare.

Further fundraising for Acuitas Medical

Acuitas Medical has secured additional fundraising from its backers as part of its plans to bring its fineSA MRI biomarker technology to market.

Sapiens secures €10 million for Parkinson’s treatment

Charitable foundation The Wellcome Trust has led a €10 million (£8.6 million) funding round for the Dutch medical device company Sapiens which is researching a treatment for Parkinson’s disease.

ISIS invests in Independent Community Care Management

Private equity firm ISIS Equity Partners has made an equity investment in Independent Community Care Management (ICCM), a live-out community care provider, through funds from the Baronsmead venture capital trusts (VCT).

Onco-NX and Kanichi share £100,000 investment

The North West Fund for Biomedical has made two further investments totalling £100,000 that will support a university spin-out and a healthcare sensor business.

Rodial founder Maria Hatzistefanis

Maria Hatzistefanis: Pay for talent

Maria Hatzistefanis, founder and president of beauty brands Rodial and Nip + Fab, tells GrowthBusiness paying for talent earlier on in her business’s life would have helped it to grow faster.

YFM leads $3 million round for Sirigen

Biomedical company Sirigen has closed a $3 million (£1.9 million) round led by YFM Equity Partners that will finance the bringing to market of its technology that tests the efficacy of drugs.

Practice Plan makes two bolt-on acquisitions

Practice Plan, a provider of dental membership plans, has acquired two businesses Isoplan and Medenta, to expand the company’s support services and move into dental patient finance.

Touch Bionics set to expand with new investment 

Funds coming from the business angel syndicate Archangels and the Scottish Venture Fund sees prosthetic technology company Touch Bionics secure £2.5 million in new investment.

SEP leads £3 million investment for Exco InTouch

Exco InTouch, a provider of patient communications products, has secured a £3 million investment that has been led by growth equity and venture capital group Scottish Equity Partners.

Ark Home acquires Anchor Trust interests

Ark Home Healthcare has acquired part of Anchor Trust, a not-for-profit housing and home care provider, with the assistance of private equity firms Ashridge Capital and Core Capital.

Horizon Discovery closes £11.3 million fundraising

Biotechnology business Horizon Discovery has raised £11.3 million in a Series C funding round after completing a private placement of ordinary shares in the Cambridge company.

Trending Topics

More from GrowthBusiness

The Entrepreneur

Smart Thinking by Art Markman

Smart Thinking by Art Markman

Stuart Kellock, managing director of Label Apeel, leafs through Art Markman's Smart Thinking to find out whether training the brain and its thought process can have any impact on his business bottom line.

Growing A Business

The Euro is at its lowest level against the Pound for three and a half years

Credit crunch 2

Christopher Shaw, CEO of invoice trading firm Platform Black, looks at why Britain's SMEs are at risk from the Eurozone crisis.

Comment & Analysis

Uncomfortable truths

There are a few golden rules to consider when rescuing a business.

Research

AIM salaries resumes upward trend

AIM pay resumes upward trend

Directors’ salaries on London’s junior market are at all-time highs, but almost half of CEOs did not get a pay rise last year.